Clinical Trial

Association Between CGM Metrics in Type 2 Diabetes Pregnancy and Perinatal Morbidity

Study acronym: PREG CGM
Completed
View on ClinicalTrials.gov →
Summary
The purpose of this observational study is to measure the association between continuous glucose monitoring (CGM) parameters and perinatal morbidity in offspring of women with type 2 diabetes. Specifically, the study will assess whether gestational age interacts with metabolic control in influencing perinatal morbidity, as well as the impact of the timing of CGM initiation during pregnancy.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-03-20; most recent amendment 2025-12-23.
Status change: Recruiting → Completed 2025-12-23
Status change: Not Yet Recruiting → Recruiting 2025-08-13
Trial Details
NCT Number NCT06892314
Lead Sponsor Centre Hospitalier Sud Francilien
Conditions Type 2 Diabetes Mellitus (T2DM), Pregnancy
Enrollment 80 participants
Start Date 2025-05-15
Primary Completion 2025-11-26 (estimated)
Study Completion 2025-11-26 (estimated)
Updated on ClinicalTrials.gov 2025-12-30